We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Xylem (XYL) Beats on Q2 Earnings, Improves 2022 Guidance
Read MoreHide Full Article
Xylem Inc.’s (XYL - Free Report) second-quarter 2022 adjusted earnings (excluding 4 cents from non-recurring items) of 66 cents per share, surpassed the Zacks Consensus Estimate of 55 cents. The bottom line was flat year over year.
Xylem’s revenues of $1,364 million also outperformed the Zacks Consensus Estimate of $1,304.3 million and inched up approximately 1% year over year. Organic sales in the quarter rose 6%, driven by higher global demand across its end markets coupled with record order and backlog across the portfolio.
Orders in the reported quarter increased 1% year over year to $1,684 million. Organically, orders grew 6% owing to robust demand.
Revenues in the Water Infrastructure segment were $589 million, up 4% year over year. Organic sales in the reported quarter grew 9% year over year, buoyed by effective price realization and healthy activity in wastewater utility business in the U.S. and Western Europe.
The Applied Water segment generated revenues of $429 million in the second quarter, up 4% year over year. Organic sales increased 7% on a year-over-year basis. Segmental performance benefited from strong price realization and backlog execution in industrial and residential end markets, partly hurt by persistent supply-chain constraints in commercial buildings in the United States.
Quarterly revenues at the Measurement & Control Solutions segment were $346 million, down 6% year over year. Organic sales were down 2% year over year due to supply-chain issues related to chips.
Margin Profile
In the reported quarter, Xylem’s adjusted EBITDA was $226 million, down 3.4% from the year-ago quarter’s level. Margin in the quarter improved 240 basis points (bps) year over year to 21.4%. Strong price realization, volume and productivity savings aided performance, despite cost inflation and high investments.
Operating income was $146 million in the quarter under review, down 8.8% year over year. The operating margin deteriorated to 10.7% in the second quarter of 2022 from 11.8% in the year-ago quarter. Interest expenses in the reported quarter totaled $12 million, down from $21 million in the year-ago quarter.
In the second quarter, Xylem’s cost of sales increased 1.6% year over year to $844 million. Selling, general and administrative expenses increased 3.3% to $314 million. Research and development expenses were flat year over year at $53 million.
Balance Sheet and Cash Flow
Exiting the second quarter, Xylem had cash and cash equivalents of $1,113 million compared with $1,349 million at the end of December 2021. Long-term debt was $1,879 million at the end of the second quarter of 2022 compared with $2,440 million at the end of December 2021.
In the first six months of 2022, Xylem generated net cash of $32 million compared with $206 million in the year-ago period. Capital expenditure was $95 million, up 18.8% year over year. Free cash flow was -$63 million in the first half of 2022 compared with +$126 million in the year-ago quarter.
Shareholder-Friendly Policies
In the first half of 2022, Xylem paid out dividends worth $110 million, reflecting an increase of 7.8% year over year. The company also bought back shares worth $52 million in the same period, down 23.5% year over year.
Outlook
Owing to strong demand, price realization and gradual easing of supply-chain constraints, Xylem raised its adjusted earnings per share guidance for the full year. It now expects the metric to be in the range of $2.50 to $2.70 compared with $2.40 to $2.70 anticipated earlier. The mid-point of the guided range — $2.60 — lies above the Zacks Consensus Estimate of $2.52.
Xylem now anticipates full-year revenues to increase 3-5% on a reported basis and 8-10% on an organic basis compared with organic revenue growth and reported revenue increase of 4-6% and 1-3% estimated earlier.
For 2022, adjusted EBITDA margin is now expected to be 16.5-17% compared with 16-17% anticipated earlier. However, the company expects its full-year performance to be hurt by cost inflation and foreign-currency headwinds.
Zacks Rank & Key Picks
Xylem carries a Zacks Rank #3 (Hold).
Some better-ranked stocks within the broader Industrial Products sector are as follows:
Greif has an estimated earnings growth rate of 36.8% for the current year. Shares of the company have gained 22.2% in the past six months.
Titan International, Inc. presently flaunts a Zacks Rank of 1. Its earnings surprise in the last four quarters was 47%, on average.
Titan International has an estimated earnings growth rate of 164.7% for the current year. Shares of the company have rallied 74.8% in the past six months.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Xylem (XYL) Beats on Q2 Earnings, Improves 2022 Guidance
Xylem Inc.’s (XYL - Free Report) second-quarter 2022 adjusted earnings (excluding 4 cents from non-recurring items) of 66 cents per share, surpassed the Zacks Consensus Estimate of 55 cents. The bottom line was flat year over year.
Xylem’s revenues of $1,364 million also outperformed the Zacks Consensus Estimate of $1,304.3 million and inched up approximately 1% year over year. Organic sales in the quarter rose 6%, driven by higher global demand across its end markets coupled with record order and backlog across the portfolio.
Orders in the reported quarter increased 1% year over year to $1,684 million. Organically, orders grew 6% owing to robust demand.
Xylem Inc. Price, Consensus and EPS Surprise
Xylem Inc. price-consensus-eps-surprise-chart | Xylem Inc. Quote
Segmental Details
Revenues in the Water Infrastructure segment were $589 million, up 4% year over year. Organic sales in the reported quarter grew 9% year over year, buoyed by effective price realization and healthy activity in wastewater utility business in the U.S. and Western Europe.
The Applied Water segment generated revenues of $429 million in the second quarter, up 4% year over year. Organic sales increased 7% on a year-over-year basis. Segmental performance benefited from strong price realization and backlog execution in industrial and residential end markets, partly hurt by persistent supply-chain constraints in commercial buildings in the United States.
Quarterly revenues at the Measurement & Control Solutions segment were $346 million, down 6% year over year. Organic sales were down 2% year over year due to supply-chain issues related to chips.
Margin Profile
In the reported quarter, Xylem’s adjusted EBITDA was $226 million, down 3.4% from the year-ago quarter’s level. Margin in the quarter improved 240 basis points (bps) year over year to 21.4%. Strong price realization, volume and productivity savings aided performance, despite cost inflation and high investments.
Operating income was $146 million in the quarter under review, down 8.8% year over year. The operating margin deteriorated to 10.7% in the second quarter of 2022 from 11.8% in the year-ago quarter. Interest expenses in the reported quarter totaled $12 million, down from $21 million in the year-ago quarter.
In the second quarter, Xylem’s cost of sales increased 1.6% year over year to $844 million. Selling, general and administrative expenses increased 3.3% to $314 million. Research and development expenses were flat year over year at $53 million.
Balance Sheet and Cash Flow
Exiting the second quarter, Xylem had cash and cash equivalents of $1,113 million compared with $1,349 million at the end of December 2021. Long-term debt was $1,879 million at the end of the second quarter of 2022 compared with $2,440 million at the end of December 2021.
In the first six months of 2022, Xylem generated net cash of $32 million compared with $206 million in the year-ago period. Capital expenditure was $95 million, up 18.8% year over year. Free cash flow was -$63 million in the first half of 2022 compared with +$126 million in the year-ago quarter.
Shareholder-Friendly Policies
In the first half of 2022, Xylem paid out dividends worth $110 million, reflecting an increase of 7.8% year over year. The company also bought back shares worth $52 million in the same period, down 23.5% year over year.
Outlook
Owing to strong demand, price realization and gradual easing of supply-chain constraints, Xylem raised its adjusted earnings per share guidance for the full year. It now expects the metric to be in the range of $2.50 to $2.70 compared with $2.40 to $2.70 anticipated earlier. The mid-point of the guided range — $2.60 — lies above the Zacks Consensus Estimate of $2.52.
Xylem now anticipates full-year revenues to increase 3-5% on a reported basis and 8-10% on an organic basis compared with organic revenue growth and reported revenue increase of 4-6% and 1-3% estimated earlier.
For 2022, adjusted EBITDA margin is now expected to be 16.5-17% compared with 16-17% anticipated earlier. However, the company expects its full-year performance to be hurt by cost inflation and foreign-currency headwinds.
Zacks Rank & Key Picks
Xylem carries a Zacks Rank #3 (Hold).
Some better-ranked stocks within the broader Industrial Products sector are as follows:
Greif, Inc. (GEF - Free Report) presently sports a Zacks Rank #1 (Strong Buy). GEF delivered a trailing four-quarter earnings surprise of 22.9%, on average. You can see the complete list of today’s Zacks #1 Rank stocks.
Greif has an estimated earnings growth rate of 36.8% for the current year. Shares of the company have gained 22.2% in the past six months.
Titan International, Inc. presently flaunts a Zacks Rank of 1. Its earnings surprise in the last four quarters was 47%, on average.
Titan International has an estimated earnings growth rate of 164.7% for the current year. Shares of the company have rallied 74.8% in the past six months.